# FDA Inspection 1191749 - Roshni Kulkarni, MD - November 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/roshni-kulkarni-md/114c80a7-81de-45ab-a329-6ab3f79ef18d
Source feed: FDA_Inspections

> FDA Inspection 1191749 for Roshni Kulkarni, MD on November 18, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191749
- Company Name: Roshni Kulkarni, MD
- Inspection Date: 2022-11-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 971017 - 2016-04-28](https://www.keypedia.com/records/fda_inspections/roshni-kulkarni-md/cfe8faed-5973-4cad-a812-01e9fac6a244)
- [FDA Inspection 839533 - 2013-07-09](https://www.keypedia.com/records/fda_inspections/roshni-kulkarni-md/0fdc369b-0a91-4de5-946e-6e22e5379d27)

Company: https://www.keypedia.com/companies/roshni-kulkarni-md/7b2e87be-e2d8-4715-aa33-3692f999ace5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d